Universitätsklinikum Heidelberg

Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany () Friedrich R, Kernder A, Blank N, Ernst D, Henes J, Keyßer G, Klemm P, et al. Journal article Castleman’s disease in the rheumatological practice () Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kötter I, Tiemann M, et al. Journal article Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia: An Observational Study () Weckler BC, Pott H, Race A, Jugkaeo N, Karki K, Ringshandl S, Seidemann C, et al. Journal article Results of a multicenter, randomized trial examining a new transition model for post-kidney transplant adolescents (2025) Kreuzer M, Prüfe J, Dierks ML, Müther S, Bethe D, Büscher A, Heindl-Rusai K, et al. Journal article Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients (2025) Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, et al. Journal article Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial (2025) Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, et al. Journal article Insights into ionic medicine: Cerium reduces the presence of reactive oxygen species and favors osteogenic over adipogenic differentiation in human mesenchymal stromal cells (2025) Westhauser F, Jacobsen V, Zheng K, Merle C, Boccaccini AR, Renkawitz T, Kunisch E Journal article Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025) Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching P, Harbeck N, et al. Journal article Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma (2025) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors (2025) Arnold L, Morak M, Kramer N, Berking C, Schefzyk M, Hassel JC, Ziemer M, et al. Journal article